CompaniesViela Bio

Viela Bio

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

10

By Phase

PHASE1: 1

By Status

TERMINATED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2019

2020

2021

2022

Today

Hover over trial bars to see details

Recent Trials

NCT04526912Lead Sponsor

Treatment and Prevention of Acute Lung Injury (ALI) in Patients With COVID-19 Infection

PHASE1Terminated

10 participants

Started: Aug 28, 2020 · Completed: May 19, 2021

Funding History (20)

8-K

Mar 15, 2021

8-K

Mar 4, 2021

8-K

Mar 1, 2021

8-K

Feb 16, 2021

8-K

Feb 1, 2021

8-K

Dec 8, 2020

8-K

Nov 10, 2020

8-K

Nov 5, 2020

8-K

Sep 15, 2020

8-K

Aug 12, 2020

Related Companies

Horizon Therapeutics

acquired